Definitive Contract 75A50121C00084

Award Date 9/30/21
Potential Completion Date 9/29/26
Potential Value $52M
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Riverwoods, IL 60015, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
3
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed

This is a federal contract award from the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency, to Baxter Healthcare Corporation (doing business as Baxter Health Systems) for the supply of Pralidoxime Chloride (PROTOPAM). The contract is a definitive contract with a firm fixed price and a ceiling value of $52,216,093.40. The contract has an ultimate completion date of September 29, 2026. Baxter Healthcare Corporation is the prime contractor and is a for-profit manufacturer of medical devices, pharmaceuticals, and biotechnology products. This contract does not have a set-aside designation. Baxter Healthcare Corporation is a major supplier of medical products to various federal agencies, including the Department of Veterans Affairs, Defense Health Agency, Indian Health Service, and ASPR. The contract award supports the delivery of pharmaceuticals and medical devices to federal customers, including the Strategic National Stockpile.

Generated 8/5/24, 9:26 AM